How many times should we screen a chemical library to discover an anticancer drug?
Author:
Publisher
Elsevier BV
Subject
Drug Discovery,Pharmacology
Reference8 articles.
1. High drug attrition rates – where are we going wrong?;Hutchinson;Nat. Rev. Clin. Oncol.,2011
2. Drug development: raise standards for preclinical cancer research;Begley;Nature,2012
3. Is poor research the cause of the declining productivity of the pharmaceutical industry? An industry in need of a paradigm shift;Sams-Dodd;Drug Discov. Today,2013
4. Phenotypic screening in cancer drug discovery – past, present and future;Moffat;Nat. Rev. Drug Discov.,2014
5. Cancer statistics, 2014;Siegel;CA Cancer J. Clin.,2014
Cited by 23 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Combined In Silico and In Vitro Analyses to Assess the Anticancer Potential of Thiazolidinedione–Thiosemicarbazone Hybrid Molecules;International Journal of Molecular Sciences;2023-12-15
2. Study of Cytotoxic Responses of Anticancer Drug Cyclophosphamide;International Journal of Advanced Research in Science, Communication and Technology;2023-12-12
3. Synthesis of alnustone-like diarylpentanoids via a 4 + 1 strategy and assessment of their potential anticancer activity;Turkish Journal of Chemistry;2023-10-31
4. Evaluation of Anticancer Activity of 76 Plant Species Collected in Andalusia (Spain) against Lung Cancer Cells;Plants;2023-09-15
5. Novel pyrrolone-fused benzosuberene MK2 inhibitors: synthesis, pharmacophore modelling, molecular docking, and anti-cancer efficacy evaluation in HNSCC cells;J BIOMOL STRUCT DYN;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3